Andrew J. Walkty

机构：University of Manitoba · ORCID：0000-0003-2880-2104

发表论文 179 篇 · 总被引 6822 次 · h-index 43

代表论文

• Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria (2022 · Drugs · 被引 47)
• Cefepime–Taniborbactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination (2024 · Drugs · 被引 28)
• Real-life experience with ceftobiprole in Canada: Results from the CLEAR (CanadianLEadership onAntimicrobialReal-life usage) registry (2021 · Journal of Global Antimicrobial Resistance · 被引 26)
• ESBL-positive Escherichia coli and Klebsiella pneumoniae isolates from across Canada: CANWARD surveillance study, 2007–18 (2021 · Journal of Antimicrobial Chemotherapy · 被引 22)
• Activity of cefepime/taniborbactam and comparators against whole genome sequenced ertapenem-non-susceptible Enterobacterales clinical isolates: CANWARD 2007–19 (2021 · JAC-Antimicrobial Resistance · 被引 21)
• Real-life experience with IV fosfomycin in Canada: Results from the Canadian LEadership on Antimicrobial Real-life usage (CLEAR) registry (2023 · Journal of Global Antimicrobial Resistance · 被引 19)